VELCADE 1 MG
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
BORTEZOMIB 1 MG
Available from:
J-C HEALTH CARE LTD
ATC code:
L01XX32
Pharmaceutical form:
POWDER FOR SOLUTION FOR INJECTION
Administration route:
I.V
Manufactured by:
JANSSEN PHARMACEUTICA N.V.,BELGIUM
Therapeutic group:
BORTEZOMIB
Therapeutic indications:
Velcade (bortezomib) for injection is indicated for the treatment of patients with multiple myeloma. Velcade (bortezomib) for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy.
Authorization date:
2012-01-01
